Tevogen Bio Holdings Inc. (NASDAQ:TVGNW) Short Interest Update

Tevogen Bio Holdings Inc. (NASDAQ:TVGNW) was the recipient of a significant growth in short interest in the month of July. As of July 31st, there was short interest totaling 5,500 shares, agrowthof52.8% from the July 15th total of 3,600 shares. Based on an average daily volume of 63,800 shares, the short-interest ratio is presently 0.1 days. Based on an average daily volume of 63,800 shares, the short-interest ratio is presently 0.1 days.

Tevogen Bio Stock Performance

TVGNW opened at $0.0612 on Thursday. Tevogen Bio has a 1-year low of $0.0099 and a 1-year high of $0.1499. The business has a 50 day moving average price of $0.07 and a two-hundred day moving average price of $0.06.

About Tevogen Bio

Tevogen Bio Holdings Inc operates as a clinical-stage specialty immunotherapy company that develops off-the-shelf precision T cell therapies for the treatment of infectious diseases, cancers, and neurological disorders. The company develops TVGN 489, which has completed Phase 1 clinical trial for the treatment and prevention of chronic lingering symptoms of the disease (Long COVID), as well as COVID-19 in B cell immune suppressed acute COVID-19 patients without a B cell cancer indication, elderly and infirm acute COVID-19 patients, and acute COVID-19 in patients on T cell suppressing drugs, including solid organ transplant patients.